Adems de reducciones de HbA1c y en peso corporal de cada vez mayor magnitud, los agonistas de GLP-1 han demostrado beneficios adicionales en reduccin de eventos cardiovasculares mayores (MACE), insuficiencia cardaca, enfermedad renal y muerte cardiovascular en las personas con DM28
the terms hypermobile EDS and hypermobility spectrum disorders will be used except when clarity dictates reference to an older diagnostic term
Saxenda: Saxenda is an FDA-approved weight loss medication that contains liraglutide, a GLP-1 receptor agonist that helps control appetite and support weight management
NICE guidance (TA875) recommends its use within specialist weight management services, with specific NHS commissioning criteria (typically BMI 35 kg/m with comorbidity, with exceptions for BMI 30-34.9) and a maximum treatment duration of 2 years
Maintaining proper hydration is a component of a healthy lifestyle
Lifestyle habits: To be effective, Semaglutide must be paired with healthy lifestyle habits (including a balanced diet and regular exercise)